世界の心不全遺伝子治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gene Therapy For Heart Failure Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2519
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、心不全遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子組み換え、遺伝子置換、その他）、用途別市場規模（病院、実験室、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・心不全遺伝子治療の市場動向
・企業の競争状況、市場シェア
・心不全遺伝子治療の種類別市場規模（遺伝子組み換え、遺伝子置換、その他）
・心不全遺伝子治療の用途別市場規模（病院、実験室、その他）
・心不全遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ）
・心不全遺伝子治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・心不全遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心不全遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・心不全遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Askbio、RENOVACORINC、Uniqure、DINAQOR、PRECIGEN、Heartseed、Cardior、NOVARTIS、Blue Rock）
・結論

Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function.

Market Analysis and Insights: Global Gene Therapy For Heart Failure Market
The global Gene Therapy For Heart Failure market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy For Heart Failure market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy For Heart Failure market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy For Heart Failure market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy For Heart Failure market.

Global Gene Therapy For Heart Failure Scope and Market Size
Gene Therapy For Heart Failure market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy For Heart Failure market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gene Modification
Gene Replacement
Others

Segment by Application
Hospital
Laboratory
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Askbio
RENOVACORINC
Uniqure
DINAQOR
PRECIGEN
Heartseed
Cardior

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy For Heart Failure Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gene Modification
1.2.3 Gene Replacement
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Therapy For Heart Failure Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy For Heart Failure Market Perspective (2016-2027)
2.2 Gene Therapy For Heart Failure Growth Trends by Regions
2.2.1 Gene Therapy For Heart Failure Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy For Heart Failure Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy For Heart Failure Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy For Heart Failure Industry Dynamic
2.3.1 Gene Therapy For Heart Failure Market Trends
2.3.2 Gene Therapy For Heart Failure Market Drivers
2.3.3 Gene Therapy For Heart Failure Market Challenges
2.3.4 Gene Therapy For Heart Failure Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy For Heart Failure Players by Revenue
3.1.1 Global Top Gene Therapy For Heart Failure Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy For Heart Failure Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy For Heart Failure Revenue
3.4 Global Gene Therapy For Heart Failure Market Concentration Ratio
3.4.1 Global Gene Therapy For Heart Failure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Heart Failure Revenue in 2020
3.5 Gene Therapy For Heart Failure Key Players Head office and Area Served
3.6 Key Players Gene Therapy For Heart Failure Product Solution and Service
3.7 Date of Enter into Gene Therapy For Heart Failure Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy For Heart Failure Breakdown Data by Type
4.1 Global Gene Therapy For Heart Failure Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2022-2027)

5 Gene Therapy For Heart Failure Breakdown Data by Application
5.1 Global Gene Therapy For Heart Failure Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Therapy For Heart Failure Market Size (2016-2027)
6.2 North America Gene Therapy For Heart Failure Market Size by Type
6.2.1 North America Gene Therapy For Heart Failure Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy For Heart Failure Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy For Heart Failure Market Size by Type (2016-2027)
6.3 North America Gene Therapy For Heart Failure Market Size by Application
6.3.1 North America Gene Therapy For Heart Failure Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy For Heart Failure Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy For Heart Failure Market Size by Application (2016-2027)
6.4 North America Gene Therapy For Heart Failure Market Size by Country
6.4.1 North America Gene Therapy For Heart Failure Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy For Heart Failure Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gene Therapy For Heart Failure Market Size (2016-2027)
7.2 Europe Gene Therapy For Heart Failure Market Size by Type
7.2.1 Europe Gene Therapy For Heart Failure Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy For Heart Failure Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy For Heart Failure Market Size by Type (2016-2027)
7.3 Europe Gene Therapy For Heart Failure Market Size by Application
7.3.1 Europe Gene Therapy For Heart Failure Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy For Heart Failure Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy For Heart Failure Market Size by Application (2016-2027)
7.4 Europe Gene Therapy For Heart Failure Market Size by Country
7.4.1 Europe Gene Therapy For Heart Failure Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy For Heart Failure Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy For Heart Failure Market Size by Type
8.2.1 Asia-Pacific Gene Therapy For Heart Failure Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy For Heart Failure Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Application
8.3.1 Asia-Pacific Gene Therapy For Heart Failure Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy For Heart Failure Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region
8.4.1 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Therapy For Heart Failure Market Size (2016-2027)
9.2 Latin America Gene Therapy For Heart Failure Market Size by Type
9.2.1 Latin America Gene Therapy For Heart Failure Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy For Heart Failure Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy For Heart Failure Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy For Heart Failure Market Size by Application
9.3.1 Latin America Gene Therapy For Heart Failure Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy For Heart Failure Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy For Heart Failure Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy For Heart Failure Market Size by Country
9.4.1 Latin America Gene Therapy For Heart Failure Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy For Heart Failure Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy For Heart Failure Market Size by Type
10.2.1 Middle East & Africa Gene Therapy For Heart Failure Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy For Heart Failure Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Application
10.3.1 Middle East & Africa Gene Therapy For Heart Failure Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy For Heart Failure Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country
10.4.1 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Askbio
11.1.1 Askbio Company Details
11.1.2 Askbio Business Overview
11.1.3 Askbio Gene Therapy For Heart Failure Introduction
11.1.4 Askbio Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.1.5 Askbio Recent Development
11.2 RENOVACORINC
11.2.1 RENOVACORINC Company Details
11.2.2 RENOVACORINC Business Overview
11.2.3 RENOVACORINC Gene Therapy For Heart Failure Introduction
11.2.4 RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.2.5 RENOVACORINC Recent Development
11.3 Uniqure
11.3.1 Uniqure Company Details
11.3.2 Uniqure Business Overview
11.3.3 Uniqure Gene Therapy For Heart Failure Introduction
11.3.4 Uniqure Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.3.5 Uniqure Recent Development
11.4 DINAQOR
11.4.1 DINAQOR Company Details
11.4.2 DINAQOR Business Overview
11.4.3 DINAQOR Gene Therapy For Heart Failure Introduction
11.4.4 DINAQOR Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.4.5 DINAQOR Recent Development
11.5 PRECIGEN
11.5.1 PRECIGEN Company Details
11.5.2 PRECIGEN Business Overview
11.5.3 PRECIGEN Gene Therapy For Heart Failure Introduction
11.5.4 PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.5.5 PRECIGEN Recent Development
11.6 Heartseed
11.6.1 Heartseed Company Details
11.6.2 Heartseed Business Overview
11.6.3 Heartseed Gene Therapy For Heart Failure Introduction
11.6.4 Heartseed Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.6.5 Heartseed Recent Development
11.7 Cardior
11.7.1 Cardior Company Details
11.7.2 Cardior Business Overview
11.7.3 Cardior Gene Therapy For Heart Failure Introduction
11.7.4 Cardior Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.7.5 Cardior Recent Development
11.8 NOVARTIS
11.8.1 NOVARTIS Company Details
11.8.2 NOVARTIS Business Overview
11.8.3 NOVARTIS Gene Therapy For Heart Failure Introduction
11.8.4 NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.8.5 NOVARTIS Recent Development
11.9 Blue Rock
11.9.1 Blue Rock Company Details
11.9.2 Blue Rock Business Overview
11.9.3 Blue Rock Gene Therapy For Heart Failure Introduction
11.9.4 Blue Rock Revenue in Gene Therapy For Heart Failure Business (2016-2021)
11.9.5 Blue Rock Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene Therapy For Heart Failure Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gene Modification
Table 3. Key Players of Gene Replacement
Table 4. Key Players of Others
Table 5. Global Gene Therapy For Heart Failure Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Therapy For Heart Failure Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gene Therapy For Heart Failure Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gene Therapy For Heart Failure Market Share by Regions (2016-2021)
Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gene Therapy For Heart Failure Market Share by Regions (2022-2027)
Table 11. Gene Therapy For Heart Failure Market Trends
Table 12. Gene Therapy For Heart Failure Market Drivers
Table 13. Gene Therapy For Heart Failure Market Challenges
Table 14. Gene Therapy For Heart Failure Market Restraints
Table 15. Global Gene Therapy For Heart Failure Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gene Therapy For Heart Failure Market Share by Players (2016-2021)
Table 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy For Heart Failure as of 2020)
Table 18. Ranking of Global Top Gene Therapy For Heart Failure Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gene Therapy For Heart Failure Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapy For Heart Failure Product Solution and Service
Table 22. Date of Enter into Gene Therapy For Heart Failure Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy For Heart Failure Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2016-2021)
Table 26. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gene Therapy For Heart Failure Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2016-2021)
Table 30. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gene Therapy For Heart Failure Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gene Therapy For Heart Failure Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gene Therapy For Heart Failure Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gene Therapy For Heart Failure Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gene Therapy For Heart Failure Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gene Therapy For Heart Failure Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gene Therapy For Heart Failure Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gene Therapy For Heart Failure Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gene Therapy For Heart Failure Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gene Therapy For Heart Failure Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Therapy For Heart Failure Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Therapy For Heart Failure Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gene Therapy For Heart Failure Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gene Therapy For Heart Failure Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gene Therapy For Heart Failure Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gene Therapy For Heart Failure Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gene Therapy For Heart Failure Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gene Therapy For Heart Failure Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Therapy For Heart Failure Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Therapy For Heart Failure Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million)
Table 62. Askbio Company Details
Table 63. Askbio Business Overview
Table 64. Askbio Gene Therapy For Heart Failure Product
Table 65. Askbio Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 66. Askbio Recent Development
Table 67. RENOVACORINC Company Details
Table 68. RENOVACORINC Business Overview
Table 69. RENOVACORINC Gene Therapy For Heart Failure Product
Table 70. RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 71. RENOVACORINC Recent Development
Table 72. Uniqure Company Details
Table 73. Uniqure Business Overview
Table 74. Uniqure Gene Therapy For Heart Failure Product
Table 75. Uniqure Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 76. Uniqure Recent Development
Table 77. DINAQOR Company Details
Table 78. DINAQOR Business Overview
Table 79. DINAQOR Gene Therapy For Heart Failure Product
Table 80. DINAQOR Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 81. DINAQOR Recent Development
Table 82. PRECIGEN Company Details
Table 83. PRECIGEN Business Overview
Table 84. PRECIGEN Gene Therapy For Heart Failure Product
Table 85. PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 86. PRECIGEN Recent Development
Table 87. Heartseed Company Details
Table 88. Heartseed Business Overview
Table 89. Heartseed Gene Therapy For Heart Failure Product
Table 90. Heartseed Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 91. Heartseed Recent Development
Table 92. Cardior Company Details
Table 93. Cardior Business Overview
Table 94. Cardior Gene Therapy For Heart Failure Product
Table 95. Cardior Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 96. Cardior Recent Development
Table 97. NOVARTIS Company Details
Table 98. NOVARTIS Business Overview
Table 99. NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 100. NOVARTIS Recent Development
Table 101. Blue Rock Company Details
Table 102. Blue Rock Business Overview
Table 103. Blue Rock Gene Therapy For Heart Failure Product
Table 104. Blue Rock Revenue in Gene Therapy For Heart Failure Business (2016-2021) & (US$ Million)
Table 105. Blue Rock Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy For Heart Failure Market Share by Type: 2020 VS 2027
Figure 2. Gene Modification Features
Figure 3. Gene Replacement Features
Figure 4. Others Features
Figure 5. Global Gene Therapy For Heart Failure Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Laboratory Case Studies
Figure 8. Others Case Studies
Figure 9. Gene Therapy For Heart Failure Report Years Considered
Figure 10. Global Gene Therapy For Heart Failure Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gene Therapy For Heart Failure Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gene Therapy For Heart Failure Market Share by Regions: 2020 VS 2027
Figure 13. Global Gene Therapy For Heart Failure Market Share by Regions (2022-2027)
Figure 14. Global Gene Therapy For Heart Failure Market Share by Players in 2020
Figure 15. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy For Heart Failure as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2020
Figure 17. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2016-2021)
Figure 18. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2022-2027)
Figure 19. North America Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gene Therapy For Heart Failure Market Share by Type (2016-2027)
Figure 21. North America Gene Therapy For Heart Failure Market Share by Application (2016-2027)
Figure 22. North America Gene Therapy For Heart Failure Market Share by Country (2016-2027)
Figure 23. United States Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gene Therapy For Heart Failure Market Share by Type (2016-2027)
Figure 27. Europe Gene Therapy For Heart Failure Market Share by Application (2016-2027)
Figure 28. Europe Gene Therapy For Heart Failure Market Share by Country (2016-2027)
Figure 29. Germany Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gene Therapy For Heart Failure Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gene Therapy For Heart Failure Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2016-2027)
Figure 39. China Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gene Therapy For Heart Failure Market Share by Type (2016-2027)
Figure 47. Latin America Gene Therapy For Heart Failure Market Share by Application (2016-2027)
Figure 48. Latin America Gene Therapy For Heart Failure Market Share by Country (2016-2027)
Figure 49. Mexico Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gene Therapy For Heart Failure Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gene Therapy For Heart Failure Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2016-2027)
Figure 55. Turkey Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gene Therapy For Heart Failure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Askbio Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 59. RENOVACORINC Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 60. Uniqure Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 61. DINAQOR Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 62. PRECIGEN Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 63. Heartseed Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 64. Cardior Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 65. NOVARTIS Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 66. Blue Rock Revenue Growth Rate in Gene Therapy For Heart Failure Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の急性心不全（AHF）治療市場規模・現状・予測（2021年-2027年）

Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0056 2021年4月 95Pages
QYResearch社発行の本調査資料では、急性心不全（AHF）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）、用途別市場規模（病院、クリニック...

世界の高血圧・心不全治療市場規模・現状・予測（2021年-2027年）

Global Hypertension and Heart Failure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3000 2021年4月 93Pages
QYResearch社発行の本調査資料では、高血圧・心不全治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（利尿薬、β遮断薬、エース阻害薬、α遮断薬、その他）、用途別市場規模（男性、女性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のうっ血性心不全用治療薬市場規模・現状・予測（2021年-2027年）

Global Medicines for Congestive Heart Failure Market Size, Status and Forecast 2021-2027
QYR2104Z3674 2021年4月 129Pages
QYResearch社発行の本調査資料では、うっ血性心不全用治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル、丸薬）、用途別市場規模（病院、家庭用、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のうっ血性心不全（CHF）市場規模・現状・予測（2021年-2027年）

Global Congestive Heart Failure (CHF) Market Size, Status and Forecast 2021-2027
QYR2104Z1539 2021年4月 130Pages
QYResearch社発行の本調査資料では、うっ血性心不全（CHF）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル、錠剤）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の慢性心不全治療市場規模・現状・予測（2021年-2027年）

Global Chronic Heart Failure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1313 2021年4月 130Pages
QYResearch社発行の本調査資料では、慢性心不全治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ICD、VAD、医薬品、その他）、用途別市場規模（病院、クリニック、家庭、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の慢性心不全治療市場規模・現状・予測（2021年-2027年）

世界のムコ多糖症遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Mucopolysaccharidosis Market Size, Status and Forecast 2021-2027
QYR2104Z2520 2021年4月 92Pages
QYResearch社発行の本調査資料では、ムコ多糖症遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、ICV、脳内、大槽内）、用途別市場規模（ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症III型A型、ムコ多糖症型III型B型）...

世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z2521 2021年4月 99Pages
QYResearch社発行の本調査資料では、卵巣がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、腫瘍内、腹腔内）、用途別市場規模（卵巣がん（詳細不明）、再発卵巣上皮がん、プラチナ耐性卵巣がん）、主要地域別市場規模（北米、ア...

世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Age-related Macular Degeneration Market Size, Status and Forecast 2021-2027
QYR2104Z2517 2021年4月 97Pages
QYResearch社発行の本調査資料では、加齢性黄斑変性症向け遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（網膜下、硝子体内）、用途別市場規模（単剤療法、併用療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z2522 2021年4月 98Pages
QYResearch社発行の本調査資料では、遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Ex vivo、In Vivo）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界のムコ多糖症遺伝子治療市場規模・現状・予測（2021年-2027年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
世界の遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …